Hepatitis C protease and polymerase inhibitors in development
about
Molecular targets for flavivirus drug discoveryTreat Early or Wait and Monitor? A Qualitative Analysis of Provider Hepatitis C Virus Treatment Decision-Making in the Context of HIV CoinfectionPatient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment.Provider and patient correlates of provider decisions to recommend HCV treatment to HIV co-infected patientsIdentification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modelingTargeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase.A localized PCR inhibitor in a porcelain crab suggests a protective role.A perspective on modelling hepatitis C virus infection.Current treatment of choice for chronic hepatitis C infection.New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.Cu(I)-catalyzed Huisgen azide-alkyne 1,3-dipolar cycloaddition reaction in nucleoside, nucleotide, and oligonucleotide chemistry.Viral response to specifically targeted antiviral therapy for hepatitis C and the implications for treatment success.Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trends.Microwave-assisted syntheses of nucleosides and their precursors.Spontaneous clearance of chronic hepatitis C infection in a patient with a 20-year-old HIV-hepatitis C co-infection and chronic active hepatitis.Green Technique-Solvent Free Microwave Synthesis and Antimicrobial Evaluation of New Thiopyridine Arabinosides.Synthesis, antiviral activity, and stability of nucleoside analogs containing tricyclic bases.Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from the Los Alamos databank.Synthesis and antiviral evaluation of 4'-C-azidomethyl-beta-D-ribofuranosyl purine and pyrimidine nucleosides.An economical synthesis of D- and L-pyrimidine arabino- and ribonucleosides.
P2860
Q21999123-15991D2B-609B-40CE-9BFF-72FF1CCB288AQ27491016-E9F80599-4351-42F6-A4DE-BE20BA5DD8CDQ30405780-A822E79B-3BD4-41CC-98C3-5F3E9BA8C31BQ30416486-113422E2-98EC-447E-903C-F051C02A2684Q30574395-117B1C84-C6C2-4F10-808F-7E566937675AQ33856419-CEA8AE4F-684E-4DF6-A4D4-FB63CC1C6043Q33899320-20F1C60B-A995-4507-9E6D-F077EA24AECBQ34620091-0D0F7DFA-CB3E-4F23-87F5-1E3E25B4AC9DQ34658820-62DC276E-8E6C-44F7-983B-662477340FA0Q34759489-5FA1868B-DC80-4CAC-88E9-5E6D829942ABQ35026621-516111D6-76A9-4973-98CF-CBB5AF80E5FCQ35653358-B52C3948-183E-49C5-A33E-F54D4652D139Q37341554-FFCC9E3A-2F0E-4859-80C9-50DB70E0F412Q37766106-C45BE9C8-8084-4E3C-8698-7763DDECE4BBQ37855863-263EBA65-5CC6-4CEA-9380-B6EA307B0FF6Q37855917-986FBB93-8C67-4BA4-B3AC-EB45097C2895Q38009784-3AA367C4-E660-4D48-AB67-F06868419D10Q39830689-4B0BAC97-325B-44C8-BEA2-7BA8A047A540Q42285080-93D61FB4-3C96-44B1-9DC4-E2EA41BF0B9BQ42694877-D62591BE-D55B-424E-BA86-73363943CDCAQ42991856-C4F76FF7-9182-42DF-8A17-A667FD16CB72Q43150230-969A0BB7-B7E7-4728-ABF8-2F692E5B9148Q46802604-A26520BB-2796-41DC-BFDD-30B5246A67F4
P2860
Hepatitis C protease and polymerase inhibitors in development
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Hepatitis C protease and polymerase inhibitors in development
@ast
Hepatitis C protease and polymerase inhibitors in development
@en
Hepatitis C protease and polymerase inhibitors in development
@nl
type
label
Hepatitis C protease and polymerase inhibitors in development
@ast
Hepatitis C protease and polymerase inhibitors in development
@en
Hepatitis C protease and polymerase inhibitors in development
@nl
prefLabel
Hepatitis C protease and polymerase inhibitors in development
@ast
Hepatitis C protease and polymerase inhibitors in development
@en
Hepatitis C protease and polymerase inhibitors in development
@nl
P2860
P356
P1476
Hepatitis C protease and polymerase inhibitors in development
@en
P2093
Gustine Liu-Young
Michael J Kozal
P2860
P304
P356
10.1089/APC.2007.0199
P577
2008-06-01T00:00:00Z